STAT3 can be activated through paracrine signaling in breast epithelial cells

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Lieblein, Jacqueline C ^a   Ball, Sarah ^a   Hutzen, Brian ^a   Sasser, A Kate ^a   Lin, Huey Jen ^a   Huang, Tim H M ^a   Hall, Brett M ^a   Lin, Jiayuh ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; STAT3 PROTEIN; VASCULOTROPIN; GLYCOPROTEIN GP 130; JANUS KINASE; STAT3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MICROENVIRONMENT; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST; BREAST TUMOR; CULTURE MEDIUM; DRUG ANTAGONISM; EPITHELIUM CELL; FIBROBLAST; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINE RECEPTOR GP130; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INTERLEUKIN-6; JANUS KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 56349107024     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-302     Document Type: Article

References (46)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007, 57(1):43-66 17237035
2. Chen WY Colditz GA Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer Nat Clin Pract Oncol 2007, 4(7):415-423 10.1038/ncponc0851 17597706
3. Evans JP Skrzynia C Susswein L Harlan M Genetics and the young woman with breast cancer Breast Dis 2005, 23:17-29 16823163
4. O'Sullivan LA Liongue C Lewis RS Stephenson SE Ward AC Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease Mol Immunol 2007, 44(10):2497-2506 10.1016/j.molimm.2006.11.025 17208301
5. Yu H Jove R The STATs of cancer - new molecular targets come of age Nat Rev Cancer 2004, 4(2): 97-105 10.1038/nrc1275 14964307
6. Haura EB Turkson J Jove R Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer Nat Clin Pract Oncol 2005, 2(6):315-324 10.1038/ncponc0195 16264989
7. Bowman T Garcia R Turkson J Jove R STATs in oncogenesis Oncogene 2000, 19(21):2474-2488 10.1038/sj.onc.1203527 10851046
8. Ihle JN The Stat family in cytokine signaling Curr Opin Cell Biol 2001, 13(2):211-217 10.1016/S0955-0674(00)00199-X 11248555
9. Darnell JE Jr STATs and gene regulation Science 1997, 277(5332):1630-1635 10.1126/science.277.5332.1630 9287210
10. Ihle JN Witthuhn BA Quelle FW Yamamoto K Silvennoinen O Signaling through the hematopoietic cytokine receptors Annu Rev Immunol 1995, 13:369-398 10.1146/annurev.iy.13.040195.002101 7612228
11. Copeland NG Gilbert DJ Schindler C Zhong Z Wen Z Darnell JE Jr Mui AL Miyajima A Quelle FW Ihle JN et al. Distribution of the mammalian Stat gene family in mouse chromosomes Genomics 1995, 29(1):225-228 10.1006/ geno.1995.1235 8530075
12. Bromberg JF Wrzeszczynska MH Devgan G Zhao Y Pestell RG Albanese C Darnell JE Jr Stat3 as an oncogene Cell 1999, 98(3):295-303 10.1016/ S0092-8674(00)81959-5 10458605
13. Hanahan D Weinberg RA The hallmarks of cancer Cell 2000, 100(1):57-70 10.1016/S0092-8674(00)81683-9 10647931
14. Yeh HH Lai WW Chen HH Liu HS Su WC Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 2006, 25(31):4300-4309 10.1038/ sj.onc.1209464 16518408
15. Buettner R Mora LB Jove R Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention Clin Cancer Res 2002, 8(4):945-954 11948098
16. Garcia R Yu CL Hudnall A Catlett R Nelson KL Smithgall T Fujita DJ Ethier SP Jove R Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells Cell Growth Differ 1997, 8(12):1267-1276 9419415
17. Watson CJ Miller WR Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts Br J Cancer 1995, 71(4):840-844 7710952
18. Bowman T Broome MA Sinibaldi D Wharton W Pledger WJ Sedivy JM Irby R Yeatman T Courtneidge SA Jove R Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis Proc Natl Acad Sci USA 2001, 98(13):7319-7324 34666 11404481 10.1073/pnas.131568898
19. Clevenger CV Roles and regulation of stat family transcription factors in human breast cancer Am J Pathol 2004, 165(5):1449-1460 1618660 15509516
20. Sung SY Hsieh CL Wu D Chung LW Johnstone PA Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance Curr Probl Cancer 2007, 31(2):36-100 10.1016/j.currproblcancer.2006.12.002 17362788
21. Ronnov-Jessen L Petersen OW Bissell MJ Cellular changes involved in conversion of nIrmal: To malignant breast: importance of the stromal reaction Physiol Rev 1996, 76(1):69-125 8592733
22. Tlsty TD Hein PW Know thy neighbor: Stromal cells can contribute oncogenic signals Curr Opin Genet Dev 2001, 11(1):54-59 10.1016/ S0959-437X(00)00156-8 11163151
23. Bhowmick NA Moses HL Tumor-stroma interactions Curr Opin Genet Dev 2005, 15(1):97-101 10.1016/j.gde.2004.12.003 15661539
24. Bhowmick NA Neilson EG Moses HL Stromal fibroblasts in cancer initiation and progression Nature 2004, 432(7015):332-337 10.1038/nature03096 15549095
25. van Roozendaal CE van Ooijen B Klijn JG Claassen C Eggermont AM Henzen-Logmans SC Foekens JA Stromal influences on breast cancer cell growth Br J Cancer 1992, 65(1):77-81 1733444
26. Kalluri R Zeisberg M Fibroblasts in cancer Nat Rev Cancer 2006, 6(5):392-401 10.1038/nrc1877 16572188
27. Yu H Kortylewski M Pardoll D Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat Rev Immunol 2007, 7(1):41-51 10.1038/nri1995 17186030
28. Lim CP Cao X Structure, function, and regulation of STAT proteins Mol Biosyst 2006, 2(11):536-550 10.1039/b606246f 17216035
29. Wen Z Darnell JE Jr Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3 Nucleic Acids Res 1997, 25(11):2062-2067 146718 9153303 10.1093/nar/25.11.2062
30. Garcia R Bowman TL Niu G Yu H Minton S Muro-Cacho CA Cox CE Falcone R Fairclough R Parsons S et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells Oncogene 2001, 20(20):2499-2513 10.1038/ sj.onc.1204349 11420660
31. Blaskovich MA Sun J Cantor A Turkson J Jove R Sebti SM Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice Cancer Res 2003, 63(6):1270-1279 12649187
32. Berishaj M Gao SP Ahmed S Leslie K Al-Ahmadie H Gerald WL Bornmann W Bromberg JF Stat3 is tyrosine-phosphorylated through the interleukin-6/ glycoprotein 130/Janus kinase pathway in breast cancer Breast Cancer Res 2007, 9(3):R32 1929096 17531096 10.1186/bcr1680
33. Chen CL Hsieh FC Lieblein JC Brown J Chan C Wallace JA Cheng G Hall BM Lin J Stat3 activation in human endometrial and cervical cancers Br J Cancer 2007, 96(4):591-599 10.1038/sj.bjc.6603597 17311011
34. Knupfer H Preiss R Significance of interleukin-6 (IL-6) in breast cancer (review) Breast Cancer Res Treat 2007, 102(2):129-135 10.1007/ s10549-006-9328-3 16927176
35. Zhong Z Wen Z Darnell JE Jr Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 1994, 264(5155):95-98 10.1126/science.8140422 8140422
36. Sasser AK Sullivan NJ Studebaker AW Hendey LF Axel AE Hall BM Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer Faseb J 2007, 21(13):3763-3770 10.1096/fj.07-8832com 17586727
37. Chang JC Wooten EC Tsimelzon A Hilsenbeck SG Gutierrez MC Tham YL Kalidas M Elledge R Mohsin S Osborne CK et al. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients J Clin Oncol 2005, 23(6):1169-1177 10.1200/ JCO.2005.03.156 15718313
38. Real PJ Sierra A De Juan A Segovia JC Lopez-Vega JM Fernandez-Luna JL Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells Oncogene 2002, 21(50):7611-7618 10.1038/sj.onc.1206004 12400004
39. Hsieh FC Cheng G Lin J Evaluation of potential Stat3-regulated genes in human breast cancer Biochem Biophys Res Commun 2005 335, 2:292-299 10.1016/j.bbrc.2005.07.075 16081048
40. Gu B Espana L Mendez O Torregrosa A Sierra A Organ-selective chemoresistance in metastasis from human breast cancer cells: Inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus Carcinogenesis 2004, 25(12):2293-2301 10.1093/carcin/bgh272 15347599
41. Duan Z Foster R Bell DA Mahoney J Wolak K Vaidya A Hampel C Lee H Seiden MV Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer Clin Cancer Res 2006, 12(17):5055-5063 10.1158/1078-0432.CCR-06-0861 16951221
42. Rincon M Broadwater G Harris L Crocker A Weaver D Dressler L Berry D Sutton L Michaelson R Messino M et al. Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: Results of cancer and leukemia group B trial 159806 Breast Cancer Res Treat 2006, 100(3):301-308 10.1007/ s10549-006-9251-7 16773437
43. Sehgal PB Tamm I Interleukin-6 enhances motility of breast cancer cells Cancer Invest 1990, 8(6):661-663 10.3109/07357909009018940 1963346
44. Conze D Weiss L Regen PS Bhushan A Weaver D Johnson P Rincon M Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells Cancer Res 2001, 61(24):8851-8858 11751408
45. Yao C Lin Y Chua MS Ye CS Bi J Li W Zhu YF Wang SM Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells Int J Cancer 2007, 121(9):1949-1957 10.1002/ijc.22930 17621625
46. Bendre MS Gaddy-Kurten D Mon-Foote T Akel NS Skinner RA Nicholas RW Suva LJ Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo Cancer Res 2002, 62(19):5571-5579 12359770